Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abivax SA - American Depositary Shares
(NQ:
ABVX
)
124.43
+5.47 (+4.60%)
Streaming Delayed Price
Updated: 10:59 AM EDT, Apr 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Abivax SA - American Depositary Shares
< Previous
1
2
Next >
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
April 01, 2026
From
Abivax
Via
GlobeNewswire
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
March 23, 2026
From
Abivax
Via
GlobeNewswire
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
February 21, 2026
From
Abivax
Via
GlobeNewswire
Abivax Provides 2026 Corporate Outlook
January 07, 2026
From
Abivax
Via
GlobeNewswire
Abivax to be Added to Nasdaq Biotechnology Index
December 18, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 17, 2025
From
Abivax
Via
GlobeNewswire
Abivax Presents Third Quarter 2025 Financial Results
December 15, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis
November 03, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies
October 06, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
October 05, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
September 29, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
September 23, 2025
From
Abivax
Via
GlobeNewswire
Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
September 12, 2025
From
Abivax
Via
GlobeNewswire
Abivax Presents First Half 2025 Financial Results
September 08, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Closing of $747.5 Million Public Offering
July 28, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
July 25, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
July 24, 2025
From
Abivax
Via
GlobeNewswire
Abivax announces trading resumption of its ordinary shares on Euronext Paris
July 24, 2025
From
Abivax
Via
GlobeNewswire
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
July 24, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Launch of Public Offering
July 23, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
July 22, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Results of its June 6, 2025 Annual General Meeting
June 11, 2025
From
Abivax
Via
GlobeNewswire
Abivax Presents First Quarter 2025 Financial Results
June 02, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
April 29, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
April 22, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
April 22, 2025
From
Abivax
Via
GlobeNewswire
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
March 26, 2025
From
Abivax
Via
GlobeNewswire
Abivax Announces Full Year 2024 Financial Results
March 24, 2025
From
Abivax
Via
GlobeNewswire
Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
February 21, 2025
From
Abivax
Via
GlobeNewswire
Abivax Publishes 2025 Financial Calendar
January 28, 2025
From
Abivax
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
